pegcetacoplan

pegcetacoplan (ASPAVELI) is an FDA-listed pharmaceutical active ingredient. Associated with Apellis Europe B.V.. Route of administration: subcutaneous. Current US regulatory status: approved.

ASPAVELI is a marketed brand name for pegcetacoplan. Check FDA Drugs@FDA for the current US label holder and prescribing information.

pegcetacoplan has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.